Literature DB >> 24846316

Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.

Z Wang1, M M Ward, L Chan, T Bhattacharyya.   

Abstract

UNLABELLED: Previous studies have shown an association between duration of bisphosphonate use and atypical femur fractures. This cohort study showed an increasingly higher risk of subtrochanteric and femoral shaft fractures among those who were more adherent to oral bisphosphonates.
INTRODUCTION: Long-term use of oral bisphosphonates has been implicated in an increased risk of atypical femur fractures located in subtrochanteric and femoral shaft regions. Another measure of drug exposure, medication adherence, however, has not been investigated.
METHODS: Among all Medicare fee-for-service female beneficiaries from 2006-2010, we followed 522,287 new bisphosphonate users from their index prescription until being censored or having a primary diagnosis of closed subtrochanteric/femoral shaft or intertrochanteric/femoral neck fractures. Data about radiographs of fracture site and features were not available. Adherence was classified according to the medication possession ratio (MPR) as the following: MPR < 1/3 as less compliant, MPR ≥ 1/3- < 2/3 as compliant, and MPR ≥ 2/3 as highly compliant. Alternative cutoff points at 50 and 80% were also used. Survival analysis was used to determine the cumulative incidence and hazard of subtrochanteric/femoral shaft or intertrochanteric/femoral neck fractures.
RESULTS: There was a graded increase in incidence of subtrochanteric/femoral shaft fractures as the level of adherence increased (Gray's test, P < 0.001). The adjusted hazard ratio (HR) for the highly compliant vs. the less compliant was 1.23 (95% Confidence Interval [CI] 1.06-1.43) overall, became significant after 2 years of follow-up (HR = 1.51, 95% CI 1.06-2.15) and reached the highest risk in the fifth year (HR = 4.06, 95% CI 1.47-11.19). However, age-adjusted incidence rates of intertrochanteric/femoral neck fractures were significantly lower among highly compliant beneficiaries, compared to less compliant users (HR = 0.69, 95% CI 0.66-0.73). Similar results were obtained when the cutoff points for being compliant and highly compliant were set at 50 and 80 %, respectively.
CONCLUSIONS: Subtrochanteric/femoral shaft fractures, unlike intertrochanteric/femoral neck fractures, are positively associated with higher adherence to long-term (≥3 years) oral bisphosphonates in the elderly female Medicare population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24846316      PMCID: PMC4254800          DOI: 10.1007/s00198-014-2738-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  26 in total

1.  Incidence and demography of femur fractures with and without atypical features.

Authors:  Adrianne C Feldstein; Dennis Black; Nancy Perrin; A Gabriela Rosales; Darin Friess; David Boardman; Richard Dell; Arthur Santora; Julie M Chandler; Mary M Rix; Eric Orwoll
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

Review 2.  Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis.

Authors:  Lydia Gedmintas; Daniel H Solomon; Seoyoung C Kim
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

3.  Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.

Authors:  Raphael P H Meier; Thomas V Perneger; Richard Stern; René Rizzoli; Robin E Peter
Journal:  Arch Intern Med       Date:  2012-06-25

4.  A semi-parametric estimate of extra-Poisson variation for vital rates.

Authors:  M P Fay; E J Feuer
Journal:  Stat Med       Date:  1997-11-15       Impact factor: 2.373

5.  Epidemiology of proximal femoral fractures in South Korea.

Authors:  Byung-Ho Yoon; Young-Kyun Lee; Sung-Chan Kim; Sang-Hwan Kim; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  Arch Osteoporos       Date:  2013-10-23       Impact factor: 2.617

6.  Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.

Authors:  Ethel S Siris; Steven T Harris; Clifford J Rosen; Charles E Barr; James N Arvesen; Thomas A Abbott; Stuart Silverman
Journal:  Mayo Clin Proc       Date:  2006-08       Impact factor: 7.616

7.  Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls.

Authors:  Jörg Schilcher; Veronika Koeppen; Jonas Ranstam; Ralf Skripitz; Karl Michaëlsson; Per Aspenberg
Journal:  Bone       Date:  2012-10-22       Impact factor: 4.398

Review 8.  Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-10-01       Impact factor: 6.741

9.  Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users.

Authors:  Jeffrey R Curtis; Andrew O Westfall; Hong Cheng; Kenneth Lyles; Kenneth G Saag; Elizabeth Delzell
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

10.  Incidence of atypical nontraumatic diaphyseal fractures of the femur.

Authors:  Richard M Dell; Annette L Adams; Denise F Greene; Tadashi T Funahashi; Stuart L Silverman; Eric O Eisemon; Hui Zhou; Raoul J Burchette; Susan M Ott
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

View more
  12 in total

1.  Atypical subtrochanteric fractures in Korean hip fracture study.

Authors:  Y-K Lee; T-Y Kim; Y-C Ha; S-H Song; J W Kim; H C Shon; J S Chang; K-H Koo
Journal:  Osteoporos Int       Date:  2017-06-14       Impact factor: 4.507

2.  The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysis.

Authors:  Caroline A Walsh; Caitriona Cahir; Sarah Tecklenborg; Catherine Byrne; Michael A Culbertson; Kathleen E Bennett
Journal:  Br J Clin Pharmacol       Date:  2019-09-06       Impact factor: 4.335

Review 3.  Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications.

Authors:  Yoshitomo Saita; Muneaki Ishijima; Kazuo Kaneko
Journal:  Ther Adv Chronic Dis       Date:  2015-07       Impact factor: 5.091

4.  Osteoporosis: A Review of Treatment Options.

Authors:  Kristie N Tu; Janette D Lie; Chew King Victoria Wan; Madison Cameron; Alaina G Austel; Jenny K Nguyen; Kevin Van; Diana Hyun
Journal:  P T       Date:  2018-02

5.  Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study.

Authors:  Bo Abrahamsen; Pia Eiken; Daniel Prieto-Alhambra; Richard Eastell
Journal:  BMJ       Date:  2016-06-28

6.  Hip and Subtrochanteric or Femoral Shaft Fractures after Bisphosphonate Use in Korean Women, Using Korean National Sample Cohort.

Authors:  Seok Hyung Won; Soyeon Ahn; Eunjeong Ji; Jung Wee Park; Jin Kak Kim; Young Kyun Lee
Journal:  J Korean Med Sci       Date:  2020-06-29       Impact factor: 2.153

7.  Incidence of atypical femoral fractures in the treatment of bone metastasis: An alert report.

Authors:  Takumi Kaku; Yoto Oh; Shingo Sato; Hirotaka Koyanagi; Takashi Hirai; Masato Yuasa; Toshitaka Yoshii; Tsuyoshi Nakagawa; Satoshi Miyake; Atsushi Okawa
Journal:  J Bone Oncol       Date:  2020-06-20       Impact factor: 4.072

8.  Localization of Atypical Femoral Fracture on Straight and Bowed Femurs.

Authors:  Young-Chang Park; Soon-Phil Yoon; Kyu Hyun Yang
Journal:  J Bone Metab       Date:  2019-05-31

Review 9.  Management of atypical femoral fracture: a scoping review and comprehensive algorithm.

Authors:  Giuseppe Toro; Cristina Ojeda-Thies; Giampiero Calabrò; Gabriella Toro; Antimo Moretti; Guillermo Martínez-Díaz Guerra; Pedro Caba-Doussoux; Giovanni Iolascon
Journal:  BMC Musculoskelet Disord       Date:  2016-05-23       Impact factor: 2.362

10.  Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea.

Authors:  Young Kyun Lee; Soyeon Ahn; Kyoung Min Kim; Chang Suk Suh; Kyung Hoi Koo
Journal:  J Korean Med Sci       Date:  2018-01-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.